Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C. (Q42978973)

12 November 2017

title

Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Martinelli AL

1

1 reference

12 November 2017

Brown D

2

1 reference

12 November 2017

Braun HB

3

1 reference

12 November 2017

Michel G

4

1 reference

12 November 2017

Dusheiko GM

5

1 reference

12 November 2017

publication date

1 January 1996

1 reference

12 November 2017

published in

Journal of Hepatology

1 reference

12 November 2017

volume

24

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

21-26

1 reference

IgM antibody to hepatitis C virus in acute and chronic hepatitis C

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Long-term persistence of IgM antibodies to HCV in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Hepatitis C virus replication and antibodies to structural and nonstructural viral proteins in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

Longitudinal study of hepatitis C viremia in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980181-4

7 January 2021

10.1016/S0168-8278(96)80181-4

Identifiers

DOI

1 reference

12 November 2017

1 reference